DCM
DGX icon

Davis Capital Management’s Quest Diagnostics DGX Stock Holding History

Davis Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$84.8K Hold
364
– – 0.05% 117
2026
Q2 		$77.2K Buy
364
+363
+36,300% +$71.2K 0.05% 128
2026
Q1 		$196 Buy
+1
New +$194 ﹤0.01% 550
2025
Q4 		– Sell
-1
Closed -$191 – 614
2025
Q3 		$191 Buy
+1
New +$177 ﹤0.01% 581

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ANBT
American National Bank & Trust Wichita Falls, Texas $1.09B AUM 26.59% 1-Year Est. Return
DM
Diversified Management Milwaukee, Wisconsin $573M AUM 24.64% 1-Year Est. Return

Davis Capital Management's DGX Position: Q3 2026 in Review

Davis Capital Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 364 shares worth $84.8K. The position accounts for 0.05% of the portfolio, ranked #117.

Davis Capital Management first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. 48 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Davis Capital Management held 364 shares of Quest Diagnostics worth $84.8K as of Q3 2026.
  • Davis Capital Management left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.05% of Davis Capital Management's portfolio in Q3 2026, its #117 holding.
  • Davis Capital Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • 48 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.